Clinical Trials Insight: 700012914

Trial Profile

Clinical Trials Insight: 700012914

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Feb 2008

At a glance

  • Drugs Ceftaroline fosamil (Primary) ; Aztreonam; Vancomycin
  • Indications Bacterial infections; Skin and soft tissue infections
  • Focus Registrational; Therapeutic Use
  • Sponsors Cerexa
  • Most Recent Events

    • 29 Feb 2008 The expected completion date for this trial is now .
    • 07 Apr 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top